Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Pranshu Mohindra

Dr. Pranshu Mohindra


Radiation oncologist Dr. Pranshu Mohindra is part of the tri-modality treatment team for the Mesothelioma and Thoracic Oncology Center at the University of Maryland Greenebaum Cancer Center in Baltimore.

Get in touch
Jump to a Topic:

About Pranshu Mohindra

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Works for Specialty Center icon

    Works for Specialty Center

  • Research Excellence icon

    Excellence in Research

  • Board Certified icon

    Board Certified in Radiation Oncology

Dr. Pranshu Mohindra, who joined the University of Maryland School of Medicine in 2014, is the lead radiologist for the acclaimed Mesothelioma and Thoracic Oncology Center. He works alongside thoracic surgeons and medical oncologists who also specialize in this rare and aggressive cancer most often caused by asbestos exposure.

They meet regularly to discuss each patient, personalizing mesothelioma treatment to best utilize the multimodality approach that has been so effective throughout the Greenebaum Cancer Center.

Those mesothelioma doctors include surgeon Dr. Joseph Friedberg and oncologist Dr. Christian Rolfo.

Mohindra’s role at Greenebaum is clinical and scientific. He works closely with pleural mesothelioma patients and with other researchers to develop novel treatments for all cancer patients.

Experience with the Latest Techniques

Mohindra is experienced in the latest radiation modalities.

His expertise includes the novel pencil-beam scanning proton therapy, intensity modulated proton therapy, intensity modulated radiation therapy, stereotactic body radiation therapy, stereotactic radiotherapy and image-guided brachytherapy.

He played a leading role in the initiation of his department’s MRI-guided brachytherapy program and is one of the few providers in the Washington, D.C., and Baltimore area with expertise in the brachytherapy procedures.

Proton therapy is a newer, precise form of radiation that treats a wide variety of solid tumors but is available only at select cancer centers around the country.

Part of Maryland’s Research Excellence

Mohindra often represents the school of medicine’s nationally recognized research efforts in radiation therapy.

One of his latest projects involves finding new ways to expand the use of proton therapy in the management of thoracic and lung malignancies, which includes mesothelioma.

“Proton therapy can better spare healthy tissue, which minimizes side effects and can help patients significantly,” he said.

His radiation oncology training included residencies at the University of Wisconsin and the Tata Memorial Centre in Mumbai, India.

Mohindra did one fellowship in head and neck cancers at Princess Margaret Hospital in Toronto, and another in global academic research at the University of Texas MD Anderson Cancer Center.

Leader of NHI-Sponsored Clinical Trials

Mohindra is heavily involved in early-stage clinical trials that study the latest radiation therapies.

He is the principal investigator of two National Cancer Institute-sponsored clinical trials, including one studying brain metastases from non-small cell lung cancer.

The University of Maryland nominated him for the Board of Directors at the Alliance for Clinical Trials in Oncology, which covers almost 10,000 cancer specialists at medical centers and hospitals across the United States and Canada.

As an associate professor at the University of Maryland, he is the director of research internships and has mentored several medical students who won national awards for research projects.

Disclaimer: Dr. Pranshu Mohindra has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. University of Maryland School of Medicine. (n.d.). Pranshu Mohindra, MD.
    Retrieved from:
  2. University of Maryland Greenebaum Comprehensive Cancer Center. (n.d.). Mesothelioma Treatment Services. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified January 10, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now